Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article from the last 30 days matching "remission"

NewsRSS4 days ago

Could My CAD Enter Remission?

Cold agglutinin disease (CAD) is a rare blood disorder where the body attacks its own red blood cells in cold temperatures. This article discusses whether CAD can go into remission, meaning the disease becomes inactive or stops progressing. The piece emphasizes that having hope about remission can be helpful for patients' mental and physical health.

WHY IT MATTERSFor CAD patients, understanding remission possibilities could change how they approach treatment and manage their condition long-term.
Good to knowcold agglutinin diseaseRead →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases